Sign In

Login

Password

Forgot Password ? Sign Up

Fokal segmentale Glomerulosklerose (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fokal segmentale Glomerulosklerose" in German language version.

refsWebsite
Global rank German rank
21doi.org
2nd place
3rd place
16zdb-katalog.de
123rd place
6th place
15nih.gov
4th place
7th place
7omim.org
4,380th place
781st place
2elsevier.com
610th place
521st place
2nejm.org
2,374th place
1,391st place
1ajkd.org
low place
low place
1biomedcentral.com
2,747th place
1,415th place
1nature.com
234th place
203rd place
1thieme-connect.de
low place
2,327th place

ajkd.org

biomedcentral.com

bmcnephrol.biomedcentral.com

  • Panupong Hansrivijit, Wisit Cheungpasitporn, Charat Thongprayoon, Nasrollah Ghahramani: Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis. In: BMC Nephrology. Band 21, Nr. 1, Dezember 2020, ISSN 1471-2369, S. 134, doi:10.1186/s12882-020-01797-7, PMID 32293308, PMC 7160971 (freier Volltext) – (biomedcentral.com [abgerufen am 11. Mai 2023]).

doi.org

  • Christina M. Wyatt, Paul E. Klotman, Vivette D. D'Agati: HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. In: Seminars in Nephrology. Band 28, Nr. 6, 2008, S. 513–522, doi:10.1016/j.semnephrol.2008.08.005, PMID 19013322.
  • Ellen T McCarthy, et al.: Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. In: Clinical Journal of the American Society of Nephrology. 5. Jahrgang, Nr. 11, November 2010, ISSN 1555-905X, S. 2115–2121, doi:10.2215/CJN.03800609, PMID 20966123.
  • Bart Smeets, et al.: Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. In: Journal of the American Society of Nephrology. 22. Jahrgang, Nr. 7, Juli 2011, ISSN 1533-3450, S. 1262–1274, doi:10.1681/ASN.2010090970, PMID 21719782.
  • Giovanna Giannico, Haichun Yang, Eric G Neilson, Agnes B Fogo: Dystroglycan in the diagnosis of FSGS. In: Clinical Journal of the American Society of Nephrology: CJASN. 4. Jahrgang, Nr. 11, November 2009, ISSN 1555-905X, S. 1747–1753, doi:10.2215/CJN.01510209, PMID 19808230.
  • Jeffrey B Kopp, et al.: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. In: Nature Genetics. 40. Jahrgang, Nr. 10, Oktober 2008, ISSN 1546-1718, S. 1175–1184, doi:10.1038/ng.226, PMID 18794856.
  • Giulio Genovese, et al.: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. In: Science. 329. Jahrgang, Nr. 5993, 13. August 2010, ISSN 1095-9203, S. 841–845, doi:10.1126/science.1193032, PMID 20647424.
  • Changli Wei, Shafic El Hindi, Jing Li, Alessia Fornoni, Nelson Goes: Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. In: Nat Med. 2011 Jul 31, doi:10.1038/nm.2411, PMID 21804539
  • Leal C Herlitz, et al.: Development of focal segmental glomerulosclerosis after anabolic steroid abuse. In: Journal of the American Society of Nephrology: JASN. 21. Jahrgang, Nr. 1, Januar 2010, ISSN 1533-3450, S. 163–172, doi:10.1681/ASN.2009040450, PMID 19917783.
  • Martin R. Pollak: Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. In: Journal of the American Society of Nephrology. Band 13, Nr. 12, 2002, ISSN 1046-6673, S. 3016–3023, doi:10.1097/01.asn.0000039569.34360.5e, PMID 12444222.
  • Elizabeth J Brown, Johannes S Schlöndorff, Daniel J Becker, Hiroyasu Tsukaguchi, Andrea L Uscinski, Henry N Higgs, Joel M Henderson, Martin R Pollak, Stephen J Tonna: Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. In: Nature Genetics. 42. Jahrgang, Nr. 1, Januar 2010, ISSN 1546-1718, S. 72–76, doi:10.1038/ng.505, PMID 20023659.
  • Caterina Mele, et al.: MYO1E mutations and childhood familial focal segmental glomerulosclerosis. In: The New England Journal of Medicine. 365. Jahrgang, Nr. 4, 28. Juli 2011, ISSN 1533-4406, S. 295–306, doi:10.1056/NEJMoa1101273, PMID 21756023.
  • Micky J Chun, Stephen M Korbet, Melvin M Schwartz, Edmund J Lewis: Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. In: Journal of the American Society of Nephrology: JASN. 15. Jahrgang, Nr. 8, August 2004, ISSN 1046-6673, S. 2169–2177, doi:10.1097/01.ASN.0000135051.62500.97, PMID 15284302.
  • Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David R.W. Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan Manuel Mejía-Vilet, Carla M. Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan-Stephan F. Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney C.W. Tang, Vladimir Tesar, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege: KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. In: Kidney International. Band 100, Nr. 4, Oktober 2021, S. S1–S276, doi:10.1016/j.kint.2021.05.021 (elsevier.com [abgerufen am 11. Mai 2023]).
  • Panupong Hansrivijit, Wisit Cheungpasitporn, Charat Thongprayoon, Nasrollah Ghahramani: Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis. In: BMC Nephrology. Band 21, Nr. 1, Dezember 2020, ISSN 1471-2369, S. 134, doi:10.1186/s12882-020-01797-7, PMID 32293308, PMC 7160971 (freier Volltext) – (biomedcentral.com [abgerufen am 11. Mai 2023]).
  • Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David R.W. Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan Manuel Mejía-Vilet, Carla M. Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan-Stephan F. Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney C.W. Tang, Vladimir Tesar, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege: KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. In: Kidney International. Band 100, Nr. 4, Oktober 2021, S. S1–S276, doi:10.1016/j.kint.2021.05.021 (elsevier.com [abgerufen am 11. Mai 2023]).
  • Thomas Osterholt, Polina Todorova, Lucas Kühne, Rasmus Ehren, Lutz Thorsten Weber, Franziska Grundmann, Thomas Benzing, Paul Thomas Brinkkötter, Linus Alexander Völker: Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS. In: Scientific Reports. Band 13, Nr. 1, 28. April 2023, ISSN 2045-2322, S. 6980, doi:10.1038/s41598-023-32576-7 (nature.com [abgerufen am 11. Mai 2023]).
  • Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David R.W. Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan Manuel Mejía-Vilet, Carla M. Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan-Stephan F. Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney C.W. Tang, Vladimir Tesar, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege: KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. In: Kidney International. Band 100, Nr. 4, Oktober 2021, ISSN 0085-2538, S. S1–S276, doi:10.1016/j.kint.2021.05.021.
  • Paul Diefenhardt, Thomas Osterholt, Paul Brinkkötter: Nephrotisches Syndrom: Überblick und Basis. In: DMW - Deutsche Medizinische Wochenschrift. Band 147, Nr. 06, März 2022, ISSN 0012-0472, S. 332–336, doi:10.1055/a-1334-2135 (thieme-connect.de [abgerufen am 11. Mai 2023]).
  • Chih-Chuan Yu, Alessia Fornoni, Astrid Weins, Samy Hakroush, Dony Maiguel, Junichiro Sageshima, Linda Chen, Gaetano Ciancio, Mohd. Hafeez Faridi, Daniel Behr, Kirk N. Campbell, Jer-Ming Chang, Hung-Chun Chen, Jun Oh, Christian Faul, M. Amin Arnaout, Paolo Fiorina, Vineet Gupta, Anna Greka, George W. Burke, III, Peter Mundel: Abatacept in B7-1–Positive Proteinuric Kidney Disease. In: New England Journal of Medicine. Band 369, Nr. 25, 19. Dezember 2013, S. 2416–2423, doi:10.1056/NEJMoa1304572 (englisch).
  • Michelle N. Rheault, Charles E. Alpers, Jonathan Barratt, Stewart Bieler, Pietro Canetta, Dong-Wan Chae, Gaia Coppock, Ulysses Diva, Loreto Gesualdo, Hiddo J.L. Heerspink, Jula K. Inrig, Gianna M. Kirsztajn, Donald Kohan, Radko Komers, Laura A. Kooienga, Kenneth Lieberman, Alex Mercer, Irene L. Noronha, Vlado Perkovic, Jai Radhakrishnan, William Rote, Brad Rovin, Vladimir Tesar, Hernán Trimarchi, James Tumlin, Muh Geot Wong, Howard Trachtman: Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. In: New England Journal of Medicine. Band 389, Nr. 26, 28. Dezember 2023, ISSN 0028-4793, S. 2436–2445, doi:10.1056/NEJMoa2308550 (nejm.org [abgerufen am 14. März 2024]).
  • Ogo Egbuna, Brandon Zimmerman, George Manos, Anne Fortier, Madalina C. Chirieac, Leslie A. Dakin, David J. Friedman, Kate Bramham, Kirk Campbell, Bertrand Knebelmann, Laura Barisoni, Ronald J. Falk, Debbie S. Gipson, Michael S. Lipkowitz, Akinlolu Ojo, Mark E. Bunnage, Martin R. Pollak, David Altshuler, Glenn M. Chertow: Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. In: New England Journal of Medicine. Band 388, Nr. 11, 16. März 2023, ISSN 0028-4793, S. 969–979, doi:10.1056/NEJMoa2202396 (nejm.org [abgerufen am 11. Mai 2023]).

elsevier.com

linkinghub.elsevier.com

  • Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David R.W. Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan Manuel Mejía-Vilet, Carla M. Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan-Stephan F. Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney C.W. Tang, Vladimir Tesar, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege: KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. In: Kidney International. Band 100, Nr. 4, Oktober 2021, S. S1–S276, doi:10.1016/j.kint.2021.05.021 (elsevier.com [abgerufen am 11. Mai 2023]).
  • Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David R.W. Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan Manuel Mejía-Vilet, Carla M. Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan-Stephan F. Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney C.W. Tang, Vladimir Tesar, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege: KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. In: Kidney International. Band 100, Nr. 4, Oktober 2021, S. S1–S276, doi:10.1016/j.kint.2021.05.021 (elsevier.com [abgerufen am 11. Mai 2023]).

nature.com

  • Thomas Osterholt, Polina Todorova, Lucas Kühne, Rasmus Ehren, Lutz Thorsten Weber, Franziska Grundmann, Thomas Benzing, Paul Thomas Brinkkötter, Linus Alexander Völker: Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS. In: Scientific Reports. Band 13, Nr. 1, 28. April 2023, ISSN 2045-2322, S. 6980, doi:10.1038/s41598-023-32576-7 (nature.com [abgerufen am 11. Mai 2023]).

nejm.org

  • Michelle N. Rheault, Charles E. Alpers, Jonathan Barratt, Stewart Bieler, Pietro Canetta, Dong-Wan Chae, Gaia Coppock, Ulysses Diva, Loreto Gesualdo, Hiddo J.L. Heerspink, Jula K. Inrig, Gianna M. Kirsztajn, Donald Kohan, Radko Komers, Laura A. Kooienga, Kenneth Lieberman, Alex Mercer, Irene L. Noronha, Vlado Perkovic, Jai Radhakrishnan, William Rote, Brad Rovin, Vladimir Tesar, Hernán Trimarchi, James Tumlin, Muh Geot Wong, Howard Trachtman: Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. In: New England Journal of Medicine. Band 389, Nr. 26, 28. Dezember 2023, ISSN 0028-4793, S. 2436–2445, doi:10.1056/NEJMoa2308550 (nejm.org [abgerufen am 14. März 2024]).
  • Ogo Egbuna, Brandon Zimmerman, George Manos, Anne Fortier, Madalina C. Chirieac, Leslie A. Dakin, David J. Friedman, Kate Bramham, Kirk Campbell, Bertrand Knebelmann, Laura Barisoni, Ronald J. Falk, Debbie S. Gipson, Michael S. Lipkowitz, Akinlolu Ojo, Mark E. Bunnage, Martin R. Pollak, David Altshuler, Glenn M. Chertow: Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. In: New England Journal of Medicine. Band 388, Nr. 11, 16. März 2023, ISSN 0028-4793, S. 969–979, doi:10.1056/NEJMoa2202396 (nejm.org [abgerufen am 11. Mai 2023]).

nih.gov

ncbi.nlm.nih.gov

omim.org

thieme-connect.de

  • Paul Diefenhardt, Thomas Osterholt, Paul Brinkkötter: Nephrotisches Syndrom: Überblick und Basis. In: DMW - Deutsche Medizinische Wochenschrift. Band 147, Nr. 06, März 2022, ISSN 0012-0472, S. 332–336, doi:10.1055/a-1334-2135 (thieme-connect.de [abgerufen am 11. Mai 2023]).

zdb-katalog.de

  • Ellen T McCarthy, et al.: Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. In: Clinical Journal of the American Society of Nephrology. 5. Jahrgang, Nr. 11, November 2010, ISSN 1555-905X, S. 2115–2121, doi:10.2215/CJN.03800609, PMID 20966123.
  • Bart Smeets, et al.: Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. In: Journal of the American Society of Nephrology. 22. Jahrgang, Nr. 7, Juli 2011, ISSN 1533-3450, S. 1262–1274, doi:10.1681/ASN.2010090970, PMID 21719782.
  • Giovanna Giannico, Haichun Yang, Eric G Neilson, Agnes B Fogo: Dystroglycan in the diagnosis of FSGS. In: Clinical Journal of the American Society of Nephrology: CJASN. 4. Jahrgang, Nr. 11, November 2009, ISSN 1555-905X, S. 1747–1753, doi:10.2215/CJN.01510209, PMID 19808230.
  • Jeffrey B Kopp, et al.: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. In: Nature Genetics. 40. Jahrgang, Nr. 10, Oktober 2008, ISSN 1546-1718, S. 1175–1184, doi:10.1038/ng.226, PMID 18794856.
  • Giulio Genovese, et al.: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. In: Science. 329. Jahrgang, Nr. 5993, 13. August 2010, ISSN 1095-9203, S. 841–845, doi:10.1126/science.1193032, PMID 20647424.
  • Leal C Herlitz, et al.: Development of focal segmental glomerulosclerosis after anabolic steroid abuse. In: Journal of the American Society of Nephrology: JASN. 21. Jahrgang, Nr. 1, Januar 2010, ISSN 1533-3450, S. 163–172, doi:10.1681/ASN.2009040450, PMID 19917783.
  • Martin R. Pollak: Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. In: Journal of the American Society of Nephrology. Band 13, Nr. 12, 2002, ISSN 1046-6673, S. 3016–3023, doi:10.1097/01.asn.0000039569.34360.5e, PMID 12444222.
  • Elizabeth J Brown, Johannes S Schlöndorff, Daniel J Becker, Hiroyasu Tsukaguchi, Andrea L Uscinski, Henry N Higgs, Joel M Henderson, Martin R Pollak, Stephen J Tonna: Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. In: Nature Genetics. 42. Jahrgang, Nr. 1, Januar 2010, ISSN 1546-1718, S. 72–76, doi:10.1038/ng.505, PMID 20023659.
  • Caterina Mele, et al.: MYO1E mutations and childhood familial focal segmental glomerulosclerosis. In: The New England Journal of Medicine. 365. Jahrgang, Nr. 4, 28. Juli 2011, ISSN 1533-4406, S. 295–306, doi:10.1056/NEJMoa1101273, PMID 21756023.
  • Micky J Chun, Stephen M Korbet, Melvin M Schwartz, Edmund J Lewis: Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. In: Journal of the American Society of Nephrology: JASN. 15. Jahrgang, Nr. 8, August 2004, ISSN 1046-6673, S. 2169–2177, doi:10.1097/01.ASN.0000135051.62500.97, PMID 15284302.
  • Panupong Hansrivijit, Wisit Cheungpasitporn, Charat Thongprayoon, Nasrollah Ghahramani: Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis. In: BMC Nephrology. Band 21, Nr. 1, Dezember 2020, ISSN 1471-2369, S. 134, doi:10.1186/s12882-020-01797-7, PMID 32293308, PMC 7160971 (freier Volltext) – (biomedcentral.com [abgerufen am 11. Mai 2023]).
  • Thomas Osterholt, Polina Todorova, Lucas Kühne, Rasmus Ehren, Lutz Thorsten Weber, Franziska Grundmann, Thomas Benzing, Paul Thomas Brinkkötter, Linus Alexander Völker: Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS. In: Scientific Reports. Band 13, Nr. 1, 28. April 2023, ISSN 2045-2322, S. 6980, doi:10.1038/s41598-023-32576-7 (nature.com [abgerufen am 11. Mai 2023]).
  • Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David R.W. Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan Manuel Mejía-Vilet, Carla M. Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan-Stephan F. Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney C.W. Tang, Vladimir Tesar, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege: KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. In: Kidney International. Band 100, Nr. 4, Oktober 2021, ISSN 0085-2538, S. S1–S276, doi:10.1016/j.kint.2021.05.021.
  • Paul Diefenhardt, Thomas Osterholt, Paul Brinkkötter: Nephrotisches Syndrom: Überblick und Basis. In: DMW - Deutsche Medizinische Wochenschrift. Band 147, Nr. 06, März 2022, ISSN 0012-0472, S. 332–336, doi:10.1055/a-1334-2135 (thieme-connect.de [abgerufen am 11. Mai 2023]).
  • Michelle N. Rheault, Charles E. Alpers, Jonathan Barratt, Stewart Bieler, Pietro Canetta, Dong-Wan Chae, Gaia Coppock, Ulysses Diva, Loreto Gesualdo, Hiddo J.L. Heerspink, Jula K. Inrig, Gianna M. Kirsztajn, Donald Kohan, Radko Komers, Laura A. Kooienga, Kenneth Lieberman, Alex Mercer, Irene L. Noronha, Vlado Perkovic, Jai Radhakrishnan, William Rote, Brad Rovin, Vladimir Tesar, Hernán Trimarchi, James Tumlin, Muh Geot Wong, Howard Trachtman: Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. In: New England Journal of Medicine. Band 389, Nr. 26, 28. Dezember 2023, ISSN 0028-4793, S. 2436–2445, doi:10.1056/NEJMoa2308550 (nejm.org [abgerufen am 14. März 2024]).
  • Ogo Egbuna, Brandon Zimmerman, George Manos, Anne Fortier, Madalina C. Chirieac, Leslie A. Dakin, David J. Friedman, Kate Bramham, Kirk Campbell, Bertrand Knebelmann, Laura Barisoni, Ronald J. Falk, Debbie S. Gipson, Michael S. Lipkowitz, Akinlolu Ojo, Mark E. Bunnage, Martin R. Pollak, David Altshuler, Glenn M. Chertow: Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. In: New England Journal of Medicine. Band 388, Nr. 11, 16. März 2023, ISSN 0028-4793, S. 969–979, doi:10.1056/NEJMoa2202396 (nejm.org [abgerufen am 11. Mai 2023]).